Xylem (XYL) EPS (Weighted Average and Diluted) (2010 - 2026)

Xylem's EPS (Weighted Average and Diluted) history runs 17 years deep, the most recent figure standing at $0.79 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 14.49% year-over-year to $0.79; the TTM figure through Mar 2026 stood at $4.02 (up 8.36% YoY), while the FY2025 annual figure was $3.92, up 7.4% from the prior year.
• EPS (Weighted Average and Diluted) was $0.79 for Q1 2026 at Xylem, down from $1.37 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.37 in Q4 2025 to a low of $0.07 in Q3 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.77 across 5 years, with a median of $0.79 in 2026.
• The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) tumbled 88.89% in 2022, then surged 800.0% in 2023.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.82 in 2022, then surged by 41.46% to $1.16 in 2023, then advanced by 14.66% to $1.33 in 2024, then advanced by 3.01% to $1.37 in 2025, then tumbled by 42.34% to $0.79 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.79 (Q1 2026), $1.37 (Q4 2025), and $0.93 (Q3 2025), per Business Quant data.